Diabetes Home > Levemir

Levemir is a drug that is approved to treat both type 1 and type 2 diabetes. This medication is a long-acting insulin, and works by providing a steady level of insulin to help control blood sugar levels throughout the day. Levemir comes in injectable form and is typically used once or twice a day. Possible side effects include low blood sugar levels and skin reactions at the injection site.

What Is Levemir?

Levemir® (insulin detemir) is a prescription diabetes medication licensed to treat both type 1 and type 2 diabetes (also known as non-insulin-dependent diabetes or adult-onset diabetes). It is a long-acting insulin, designed to be taken once or twice a day.
 
(Click Levemir Uses for more information, including possible off-label uses.)
 

Who Makes Levemir?

Levemir is manufactured by Novo Nordisk.
 

Effects

Studies have shown that once- or twice-daily Levemir works similarly to once- or twice-daily NPH insulin (an intermediate-acting insulin) in adults and children with type 1 diabetes and in adults with type 2 diabetes. Studies have also shown that twice-daily Levemir works similarly to once-daily insulin glargine (Lantus®), a long-acting insulin, in adults with type 1 diabetes.
 
More importantly, studies seem to suggest that people may gain less weight with Levemir, compared to those using Lantus or NPH insulin, although further research is necessary to confirm these findings.
 
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation
Advertisement


Topics

Medications

Quicklinks

Related Channels

eMedTV Links
Copyright © 2006-2017 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.